Ondansetron
Product Images NDC 68071-2652

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68071-2652). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2652 4)

Pdp (68071 2652 4)
ONDANSETRON 8mg tablet label from NuCare Pharmaceuticals, Inc. The label indicates 8mg orally disintegrating tablets (#4 ODT) with phenylalanine content warning. It includes product number P1758004, barcode, and storage instructions at controlled temperature 68-77°F. Additional details show manufacturing and packaging by Sun Pharmaceutical Industries Ltd., India, and an Rx Only designation.*
FDA Label Image

Ondansetron-structure (Ondansetron Structure)

Ondansetron-structure (Ondansetron Structure)
Chemical structure of Ondansetron, depicting its molecular framework with labeled rings and substituents including a methyl group, ketone, and heterocyclic components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.